There are no easy answers when it comes to mandatory testing ofnewborns for HIV. In a year when about 250 US infants are expectedto be born HIV positive with no advance warning or maternaltesting, ethics, politics, and costs are colliding in an explosionof argument, opinion, and data.
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Andrew Alexis, MD, MPH, highlights positive lebrikizumab-lbkz data for atopic dermatitis
June 25th 2025Lebrikizumab demonstrated efficacy and safety in patients with skin of color and moderate-to-severe atopic dermatitis in the ADmirable trial. Trial investigator Andrew Alexis, MD, MPH, reacts.